Maneesh Jain

Title: Maneesh Jain: Innovator in Cancer Detection and Treatment

Introduction

Maneesh Jain is a prominent inventor based in Omaha, NE (US). He has made significant contributions to the field of cancer research, particularly in the detection and treatment of various types of cancer. His innovative work has the potential to impact the lives of many patients facing these challenging diseases.

Latest Patents

Maneesh Jain holds a patent for "Compositions and methods for detection and treatment of cancer." This patent focuses on novel antibodies designed for the detection and/or treatment of cancers, such as pancreatic and ovarian cancer. The antibodies bind to specific regions of the MUC4 protein, excluding the central tandem repeat (TR) domain. Notably, certain antibodies target the MUC4 peptide fragments MUC4-α-N-Ter and MUC4-α-C-Ter. Additionally, chimeric constructs that incorporate these antibodies are also included in his patent.

Career Highlights

Maneesh Jain is affiliated with the Board of Regents of the University of Nebraska, where he continues to advance his research in cancer detection and treatment. His work is characterized by a commitment to innovation and a focus on developing effective solutions for complex medical challenges.

Collaborations

Maneesh has collaborated with notable colleagues, including Moorthy P Ponnusamy and Surinder K Batra. These partnerships enhance the research efforts and contribute to the development of groundbreaking technologies in the field of oncology.

Conclusion

Maneesh Jain's contributions to cancer research through his innovative patents and collaborations highlight his dedication to improving patient outcomes. His work exemplifies the importance of innovation in the medical field, particularly in the fight against cancer.